Our results around the frequency of experiencing a decreased sex drive (in the past year) appear higher than Lin et al., who surveyed estrogen receptor-positive breast cancer patients on ET and reported decreased libido in 24% of ET users in the past seven days [14]. Here, ESR1 is linked to breast carcinoma.